Stress-related neuropeptides and VTA dopamine neurons

压力相关神经肽和 VTA 多巴胺神经元

• 批准号: 7238862
• 负责人: Matthew J. Wanat
• 金额: $ 0.78万
• 依托单位: ERNEST GALLO CLINIC AND RESEARCH CENTER
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-05-01 至 2007-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7238862
• 关键词: Affect; Behavior; Brain; Cells; Corticotropin; Corticotropin-Releasing Hormone; Data; Dopamine; Drug Addiction; Fire - disasters; Incidence; Midbrain structure; Motor Activity; Neuropeptides; Pharmaceutical Preparations; Pharmacology; Prefrontal Cortex; Preparation; Rate; Relapse; Signal Pathway; Slice; Stimulus; Stress; Stressful Event; Substance P; Therapeutic; Ventral Tegmental Area; Voltage-Clamp Technics; Whole-Cell Recordings; Work; addiction; dopaminergic neuron; drug seeking behavior; insight; neural circuit; novel therapeutics; prevent; receptor; research study; therapeutic target

DESCRIPTION (provided by applicant): One major problem involved with treating drug addiction is the high incidence of relapse to drug taking, which often is triggered by stressful events. Stress induces the release of dopamine, and the increased levels of dopamine are required for relapse to drug seeking. Thus, preventing stress-induced dopamine release may have therapeutic implications in reducing the incidence of relapse. The proposed research studies how stress affects dopamine-producing cells in order to identify targets which could prevent stress- induced dopamine release. Stress induces the release of corticotropin-releasing factor (CRF) and substance P (SP) onto dopamine cells. The aims of this proposal are to identify the mechanisms by which CRF and SP affect the firing of dopamine cells. Specifically, this project will determine the receptors, the intracellular signaling pathways, and the currents that are altered by CRF and SP. Potential therapeutic targets for reducing the incidence of stress-induced relapse will be identified through determining the mechanism through which SP and CRF act on dopamine neurons.

描述（由申请人提供）：治疗药物成瘾的一个主要问题是复吸率高，这通常是由压力事件引发的。压力诱导多巴胺的释放，而多巴胺水平的增加是药物寻求复发所必需的。因此，预防应激诱导的多巴胺释放可能在降低复发率方面具有治疗意义。这项拟议中的研究研究了压力如何影响多巴胺产生细胞，以确定可以阻止压力诱导的多巴胺释放的靶点。应激诱导促肾上腺皮质激素释放因子（CRF）和P物质（SP）释放到多巴胺细胞上。该建议的目的是确定CRF和SP影响多巴胺细胞放电的机制。具体而言，该项目将确定受体，细胞内信号通路，并改变CRF和SP的电流。通过确定SP和CRF作用于多巴胺神经元的机制，将确定潜在的治疗靶点，以减少应激诱发复发的发生率。